| Vol.
1 Issue 08 Friday, October 26, 2007 |
|
|
Commercial
Scale
Alendronate sodium
Arteether
Artemether
Artesunate
Azithromycin
Cetirizine dihydrochloride
Chloramphenicol palmitate
Clopidogrel bisulphate
Coenzyme Q10
Dihydroartemisinin
Erythromycin base
Erythromycin estolate
Erythromycin ethyl succinate
Erythromycin oxime (intermediate)
Erythromycin phosphate
Erythromycin propionate
Erythromycin stearate
Isoniazid
Lisinopril dihydrate
Losartan potassium
Pyrazinamide
Rifampicin
Roxithromycin
Sodium valproate
Valproic acid
Venlafaxine hydrochloride
Zoledronic acid
Zopiclone
Pilot Plant Scale
Carvedilol
Clarithromycin
Pioglitazone hydrochloride
Rosiglitazone maleate
Valsartan
R & D Scale
Lumefantrine
Pamidronate disodium
Perindopril erbumine
Zolpidem tartrate
Development
Benazepril hydrochloride
Candesartan
Desvenlafaxine
Glipizide
Irbesartan
Levocetirizine
Rifabutin
Rifapentine
Ramipril
Risedronic acid
Telmisartan
Product
under patent offered only
for exempted research, clinical
and
development purposes.
Only non-
infrining products
and processes
are offered, subject to
patent status
verification by client. |
• Custom Syntheses
• Contract Manufacturing
• FTE Research
• Analytical Support
• Intermediates & APIs
• Building Blocks
|
|
 |
Diwali : The festival
of lights
The growing ethnic and cultural
diversity of Indian community throughout
the world provides the opportunity
to participate in the celebrations and rituals
of Diwali festival that enhances the feelings of
being part of a close
-knit group of Indians. Most Diwali
celebrations around the world focus on family
and friends and it is a time to reflect on the past
and envision for a future,
perhaps, in a world where people live together in harmony.
|
The
festival of Diwali heralds the
victory of good over evil, light over darkness,
knowledge over ignorance, joy, mirth and
happiness in the life of every individual. |
|
Press
release in ‘The Economic Times’
Calyx Chemicals to set up R&D centre in Mumbai
12 Oct, 2007, 2052 hrs IST, PTI
NEW DELHI: Drug firm Calyx Chemicals and Pharmaceuticals
is investing Rs 40 crore to set up a research
and development centre in Dombivli near Mumbai as part of
its plans to expand its research and manufacturing services
business.
"Going
forward, we want to expand our Contract Research and
Manufacturing Services (CRAMS) capability and
would invest
Rs 40 crore in setting up a R&D centre near Mumbai,"
Calyx Chemicals and Pharmaceuticals President
(R&D) and Executive Director Bansi Lal told media on the
sidelines of a CII event.
He
said the R&D centre would employ up to 300 scientists
and is expected to be operational by early
next year. The company
is half way through construction and installation of equipment
at the centre, he added.
"With
the R&D centre operational by early 2008 and expansion
in our capacities, we would like to be a major player in CRAMS
segment," Dr. Bansi Lal
added.
|
|
Challenges and Opportunities
in CRAMS Business
Highlights of Presentation by Dr. Bansi
Lal at the “CII Lifesciences Conclave 2007” in Delhi,
India, October 12 - 13, 2007
Emerging
Global Scenario
• Introduction of new drugs on global scale has
come down.
Cost per molecule introduction has further
gone up > US $ 1 billion.
• Pressure on cost & profit is very high.
• Competition is increasing every day.
• Products are going out of patents.
• Globalization is getting real.
• Old models of doing business are not effective.
• Mergers have been partially successful.
• Business needs a paradigm shift.
• Hence outsourcing is a must.
• Therefore the birth of CRAMS. |
 |
|
Areas of Contract Research & Manufacturing
• APIs
• Intermediates
• Drug Discovery
• Formulations
• Clinical trials
• Other Chemicals
APIs,
Other Chemicals & Formulations
• Develop API (CTD) in cGMP & non GMP
• Material for Stability / toxicology study
• Kilo scale production, Material for Preclinical,
Phase I, II.
• Process development, optimization and validation
• HAZOP, Automation, New Technology generation
• Specialty chemicals, Agrochemicals
• Diagnostics, Electronics, Textiles
• Formulations of Old and New Molecules
• PDL --> Kilo scale --> Small scale -->
Medium scale --> Large scale |
 |
|
|
|
 |
Disclaimer:
"The information in this e-mail and any attachments
is confidential and may be legally privileged. It is intended solely
for the addressee or addressees. If you are not an intended recipient,
please delete the message and any attachments and
notify the sender of misdelivery. Any use or disclosure of the
contents of either is unauthorized and may be
unlawful. All liability for viruses is excluded to the
fullest extent permitted by law. Any views expressed
in this message are those of the individual sender, except where
the sender states them, with requisite authority, to be
those of the specific Calyx company." |
| To
unsubscribe from this Newsletter send blank email to pharmanews@calyxindia.com
|
| “Meet
us at at
CPhI India 2007, at Bombay Exhibition Centre, Mumbai, India.
November 25 -
27 2007, at Hall- 5, Stand No: B12”
|
 |
|
